Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense (QFR105385USNO)

Observation:

Q2 2024: 8,257 (+ more)  Updated: Sep 10, 2024 9:09 AM CDT
Q2 2024:  8,257  
Q1 2024:  7,326  
Q4 2023:  7,594  
Q3 2023:  7,238  
Q2 2023:  6,614  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Title Release Dates

2017-09-06 2024-09-10
 
Source    

2017-09-06 2024-09-10
 
Release    

2017-09-06 2024-09-10
 
Units    

2017-09-06 2024-09-10
 
Frequency    

2017-09-06 2024-09-10
 
Seasonal Adjustment    

2017-09-06 2024-09-10
 
Notes    

2017-09-06 2024-09-10

Top